Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Jesus Bermejo"'
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S446- (2023)
Externí odkaz:
https://doaj.org/article/029c510233b8420d99b5287de40b9600
Autor:
Pablo Miaja Hernandez, Miguel Angel Garitagoitia Romero, Marcos Martinez Baños, Maria Jesus Bermejo, Paola Bovolenta
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S451- (2023)
Externí odkaz:
https://doaj.org/article/6106407b0e2e44549d94a85ada682783
Autor:
Eulalia Jimenez, Carol Astbury, Muna Albayaty, Ulrika Wählby-Hamrén, Beatriz Seoane, Cristina Villarroel, Helena Pujol, Maria Jesus Bermejo, Ajay Aggarwal, Ioannis Psallidas
Publikováno v:
Respiratory Research, Vol 21, Iss S1, Pp 1-9 (2020)
Abstract Background Navafenterol (AZD8871) is an inhaled long-acting dual-pharmacology muscarinic antagonist/β2-adrenoceptor agonist (MABA) in development for the treatment of obstructive airways diseases. The safety, tolerability, pharmacodynamics,
Externí odkaz:
https://doaj.org/article/5eb0ee5d18dd4886a2482e4d36b7db73
Autor:
Maria-Jesus Bermejo, Cristina Villarroel, Carol Astbury, Helena Pujol, Ajay Aggarwal, Beatriz Seoane, Lali Jimenez, Muna Albayaty
Publikováno v:
Airway Pharmacology and Treatment.
AZD8871 is an inhaled long acting dual muscarinic antagonist/ β 2 adrenoceptor agonist (MABA) under development for the treatment of COPD and asthma. This was an ascending-dose first in man trial, designed to test safety, tolerability, pharmacokinet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef1f1e2e9eddf15168071dc78379d2d7
https://doi.org/10.1183/1393003.congress-2017.pa1811
https://doi.org/10.1183/1393003.congress-2017.pa1811